{"id":43146,"date":"2016-07-14T00:00:00","date_gmt":"2016-07-13T22:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/invent-pharma-palex-ma-sector-sanitario-junio-2016\/"},"modified":"2025-03-12T11:38:08","modified_gmt":"2025-03-12T10:38:08","slug":"invent-pharma-palex-ma-sector-sanitario-junio-2016","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/invent-pharma-palex-ma-sector-sanitario-junio-2016\/","title":{"rendered":"Invent Pharma and Palex: Healthcare M&amp;A June 2016"},"content":{"rendered":"<h5><span class=\"ez-toc-section\" id=\"Las_firmas_de_capital_riesgo_estan_impulsando_el_sector_sanitario_en_Espana_Este_mes_hemos_conocido_que_Corpfin_ha_comprado_Palex_empresa_de_dispositivos_medicos_para_que_esta_pueda_tener_la_liquidez_suficiente_para_realizar_fusiones_y_adquisiciones_Ademas_Apax_Partners_tambien_ha_apostado_fuerte_por_el_sector_y_ha_comprado_Invent_Pharma_por_E220M\"><\/span><span style=\"color: #000000;\">Venture capital firms are boosting the healthcare sector in Spain. This month we learned that Corpfin has bought Palex, a medical device company, to provide it with sufficient liquidity to make <a href=\"https:\/\/techma.bakertilly.es\/en\/merger-and-acquisition-m-a\/\" target=\"_blank\">mergers and acquisitions<\/a>. In addition, Apax Partners has also invested heavily in the sector and bought Invent Pharma for \u20ac220M.<\/span><!--more--><span class=\"ez-toc-section-end\"><\/span><\/h5>\n<h5><span class=\"ez-toc-section\" id=\"Apax_Partners_compra_Invent_Pharma_por_E220M\"><\/span><span style=\"color: #3366ff;\"><strong>Apax Partners buys Invent Pharma for \u20ac220M<\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h5>\n<p><span style=\"color: #000000;\"><span style=\"text-decoration: underline;\">Invent Farma,<\/span> a laboratory based in Sant Joan Desp\u00ed (Baix Llobregat), is changing hands once again. Apax Partners has closed for about \u20ac220M the purchase of the pharmaceutical group comprising Laboratorios Lesvi, Inke and Quilaten.<\/span><\/p>\n<p><span style=\"color: #000000;\">This operation is the first one that the British fund has carried out in Catalonia since 2007, when it took control of<span style=\"text-decoration: underline;\"> <a href=\"http:\/\/www.grupoelectrostocks.com\/es\/Default.aspx\" target=\"_blank\" rel=\"noopener\">Electro Stocks Group<\/a><\/span>a company dedicated to the professional distribution of electrical, automation, air conditioning and plumbing equipment, in which it now holds the entire share capital.<\/span><\/p>\n<p><span style=\"color: #000000;\">Invent Farma has its origins in 2004, when Icelandic pharmaceutical entrepreneur Fridrik Steinn Kristj\u00e1nsson bought industrial assets from the former Catalan group Vita. Kristj\u00e1nsson divested most of his stake in 2013 in favour of Icelandic funds.<\/span><\/p>\n<p><span style=\"color: #000000;\">The laboratory manufactures active pharmaceutical ingredients in Castellbisbal (Vall\u00e8s Occidental) for its own products and for third parties; its customers include European and Japanese pharmaceutical companies.<\/span><\/p>\n<p><span style=\"color: #000000;\">In recent years, Invent Farma, which employs 430 people, has specialised in niche products, particularly in the respiratory and ophthalmology fields. The company made the leap to the United States in 2015, when it set up its first subsidiary in New Jersey. The subsidiary is focused solely on commercial functions.<\/span><\/p>\n<h5><span class=\"ez-toc-section\" id=\"Corpfin_compra_Palex_para_dar_musculo_financiero_al_grupo_que_quiere_realizar_fusiones_y_adquisiciones\"><\/span><span style=\"color: #3366ff;\"><strong>Corpfin compra Palex, para dar musculo financiero al grupo que quiere realizar <a href=\"https:\/\/techma.bakertilly.es\/en\/merger-and-acquisition-m-a\/\" target=\"_blank\">mergers and acquisitions<\/a><\/strong><\/span><span class=\"ez-toc-section-end\"><\/span><\/h5>\n<p><span style=\"color: #000000;\">The Knuth family, founder and owner of Palex, has decided to sell a majority stake in the healthcare technology group to a private equity fund. <span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.corpfincapital.com\/\" target=\"_blank\" rel=\"noopener\">Corpfin<\/a>.<\/span> The aim of the operation is for Palex to gain financial muscle to embark on a new phase of growth by acquiring companies in the sector and diversifying its business lines.<span style=\"text-decoration: underline;\"> <a href=\"http:\/\/www.palexmedical.com\/es\/index.cfm\" target=\"_blank\" rel=\"noopener\">Palex<\/a><\/span> ya tiene sobre la mesa varias <a href=\"https:\/\/techma.bakertilly.es\/en\/merger-and-acquisition-m-a\/\" target=\"_blank\">mergers and acquisitions<\/a> y contar\u00e1 a partir de ahora con la experiencia de Corpfin Capital en materia de integraciones y procesos de build up.<\/span><\/p>\n<p><span style=\"color: #000000;\">Headquartered in Sant Cugat del Vall\u00e8s and with a workforce of 300, the healthcare technology and supplies group operates through ten divisions and markets the products of more than 400 international companies. Palex Medical, which does not manufacture, is particularly strong in technology and instruments for cardiac surgery, such as valves and pacemakers. Orthopaedic surgery is another of its business pillars, along with diagnostics and nephrology. Its star products include a device that allows dialysis to be performed at the patient's home and Oncotype, a predictive test for breast cancer. Werfen, also from Catalonia, is one of its main competitors.<\/span><\/p>\n<h5><span class=\"ez-toc-section\" id=\"Otros_post_que_te_pueden_interesar\"><\/span><strong><span style=\"color: #0000ff;\">Other posts that may interest you<\/span><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h5>\n<p><span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/inveready-apuesta-por-la-biotecnologia-en-menos-de-1-mes-invierte-en-cuantum-ab-biotics\/\">Inveready bets on biotechnology, invests in Cuantum and AB-biotics in less than a month<\/a><\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/los-inversores-pierden-el-miedo-de-invertir-en-biotecnologia\/\">Investors lose their fear of investing in biotechnology<\/a><\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/las-biotecnologicas-espanolas-salen-bolsa\/\">Spanish biotech companies go public<\/a><\/span><\/p>\n<p><span style=\"color: #000000;\">If you are looking for financing for your company, contact us. Abra-Invest has a team of experts in alternative financing at your disposal with extensive experience in the biotech sector. Call us on + 34 944240141 or fill in the contact form. <\/span>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Private equity firms are driving the healthcare sector in Spain. This month we learned that Corpfin has bought Palex, a medical devices company, to give it sufficient liquidity to carry out mergers and acquisitions. In addition, Apax Partners has also invested heavily in the sector and bought Invent Pharma for \u20ac220M.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2277],"tags":[296,654,334,655],"sectores":[],"tipo-contenido":[2260],"class_list":["post-43146","post","type-post","status-publish","format-standard","hentry","category-multiplos-de-empresas-cotizadas","tag-capital-riesgo-2015","tag-ma-biotecnologia","tag-ma-espana","tag-ma-sector-salud","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/43146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=43146"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/43146\/revisions"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=43146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=43146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=43146"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=43146"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=43146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}